Suchergebnisse - Mark E. Robson
- Treffer 1 - 20 von 147
- Zur nächsten Seite
-
1
-
2
Revealing the Incidentalome When Targeting the Tumor Genome von Yvonne Bombard, Mark E. Robson, Kenneth Offit
Veröffentlicht 2013Artigo -
3
-
4
Cancer Genomics and Inherited Risk von Zsofia K. Stadler, Kasmintan A. Schrader, Joseph Vijai, Mark E. Robson, Kenneth Offit
Veröffentlicht 2014Artigo -
5
-
6
-
7
-
8
Localized male breast carcinoma and family history von Arnold Hill, Yusuf Yağmur, Katherine N. Tran, John S. Bolton, Mark E. Robson, Patrick I. Borgen
Veröffentlicht 1999Artigo -
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based Differences von Jada G. Hamilton, Elyse Shuk, Guedy Arniella, Carlos Javier Álvarez González, Geoffrey S. Gold, Francesca Gany, Mark E. Robson, Jennifer L. Hay
Veröffentlicht 2015Artigo -
17
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency von Kutluk Oktay, Giuliano Bedoschi, Shari Goldfarb, Enes Taylan, Shiny Titus, Glenn E. Palomaki, Tessa Cigler, Mark E. Robson, Maura N. Dickler
Veröffentlicht 2020Artigo -
18
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers von Sara P. Myers, Varadan Sevilimedu, Andrea V. Barrio, Audree B. Tadros, Anita Mamtani, Mark E. Robson, Monica Morrow, Minna K. Lee
Veröffentlicht 2024Artigo -
19
-
20
Suchwerkzeuge:
Ähnliche Schlagworte
Cancer
Medicine
Internal medicine
Biology
Oncology
Genetics
Gene
Breast cancer
Mutation
Germline mutation
Germline
Cancer research
BRCA mutation
Pathology
Genetic testing
Computational biology
Ovarian cancer
Gynecology
Population
Environmental health
Allele
Bioinformatics
Metastatic breast cancer
Genotype
Phenotype
Chemotherapy
CHEK2
Confidence interval
PALB2
Colorectal cancer